Literature DB >> 14973376

Interrogating mouse mammary cancer models: insights from gene expression profiling.

Antonio A Fargiano1, Kartiki V Desai, Jeffrey E Green.   

Abstract

Numerous mouse models for mammary cancer have been developed and characterized based upon their biological, molecular, and histopathological features. In an effort to dissect the molecular anatomy of such models and compare their gene expression profiles to those of human breast cancer, six models representing various oncogenic pathways have been investigated using cDNA microarray technology. Results of these analyses are presented and discussed in the context of technological challenges presented by analyzing data on such a large scale. Further expression profiling coupled with emerging proteomic technologies will more completely define and distinguish mouse models of mammary cancer from each other and provide a comprehensive basis for comparing such models with the human disease they are intended to represent.

Entities:  

Mesh:

Year:  2003        PMID: 14973376     DOI: 10.1023/b:jomg.0000010032.05234.6f

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  88 in total

Review 1.  Genomics, gene expression and DNA arrays.

Authors:  D J Lockhart; E A Winzeler
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

Review 2.  Statistical design and the analysis of gene expression microarray data.

Authors:  M K Kerr; G A Churchill
Journal:  Genet Res       Date:  2001-04       Impact factor: 1.588

3.  DNA arrays for analysis of gene expression.

Authors:  M B Eisen; P O Brown
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 4.  General keynote: expression of epidermal growth factor receptor family in transgenic mouse models of human breast cancer.

Authors:  William J Muller
Journal:  Gynecol Oncol       Date:  2003-01       Impact factor: 5.482

Review 5.  Transgenic mouse models of human breast cancer.

Authors:  J N Hutchinson; W J Muller
Journal:  Oncogene       Date:  2000-12-11       Impact factor: 9.867

Review 6.  Validity of mouse mammary tumour models for human breast cancer: comparative pathology.

Authors:  R D Cardiff
Journal:  Microsc Res Tech       Date:  2001-01-15       Impact factor: 2.769

7.  The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

Authors:  P J Coopman; M T Do; M Barth; E T Bowden; A J Hayes; E Basyuk; J K Blancato; P R Vezza; S W McLeskey; P H Mangeat; S C Mueller
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 8.  BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.

Authors:  M O Nicoletto; M Donach; A De Nicolo; G Artioli; G Banna; S Monfardini
Journal:  Cancer Treat Rev       Date:  2001-10       Impact factor: 12.111

9.  Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.

Authors:  Tatsuya Toyama; Hirotaka Iwase; Hiroko Yamashita; Yasuo Hara; Yoko Omoto; Hiroshi Sugiura; Zhenhuan Zhang; Yoshitaka Fujii
Journal:  Cancer Lett       Date:  2003-01-10       Impact factor: 8.679

10.  Molecular characterization of the murine syk protein tyrosine kinase cDNA, transcripts and protein.

Authors:  M Flück; G Zürcher; A C Andres; A Ziemiecki
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

View more
  3 in total

Review 1.  Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential.

Authors:  Airo Tsubura; Katsuhiko Yoshizawa; Norihisa Uehara; Takashi Yuri; Yoichiro Matsuoka
Journal:  Med Mol Morphol       Date:  2007-03-29       Impact factor: 2.309

2.  Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.

Authors:  Alfonso Calvo; Carlos Perez-Stable; Victor Segura; Raúl Catena; Elizabeth Guruceaga; Paul Nguewa; David Blanco; Luis Parada; Teresita Reiner; Jeffrey E Green
Journal:  Prostate       Date:  2010-05-01       Impact factor: 4.104

3.  Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice.

Authors:  Sarah A Davie; Jeannie E Maglione; Cathyryne K Manner; Dmitri Young; Robert D Cardiff; Carol L MacLeod; Lesley G Ellies
Journal:  Transgenic Res       Date:  2007-01-06       Impact factor: 2.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.